TrialMedical oncology (Northwood, London, England)2011

Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study.

Antonio Rozzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.